Keywords: Merck & Co, Isentress, Gilead Sciences, Stribild, Complera, HIV, Hepatitis C

Merck & Co and Gilead highlight new data at international HIV meeting

Article | 16 November 2012

Print This

US pharma giant Merck & Co (NYSE: MRK)presented new data at the 11th International Congress on HIV and Drug ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in